The Valley Desk

NCT03098030 · Interventional trial

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

Overall registry status Completed

Phase 2 · Phase 3

Conditions Small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov